Exogenous morphine inhibits human gastric cancer MGC-803 cell growth by cell cycle arrest and apoptosis induction

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1377-1382

  Qin, Yi ^a   chen, Jing ^a   Li, Li ^a   Liao, Chun Jie ^a   Liang, YU Bing ^a   Guan, En Jian ^a   Xie, Yu Bo ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis.; Cell cycle arrest; Gastric cancer; Morphine

Indexed keywords

BIRC5 PROTEIN, HUMAN; CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; MORPHINE; NARCOTIC ANALGESIC AGENT;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; SCANNING ELECTRON MICROSCOPY; STOMACH TUMOR; TUMOR CELL LINE;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; APOPTOSIS; CARCINOMA; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROSCOPY, ELECTRON, SCANNING; MORPHINE; NF-KAPPA B; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84873028097     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1377     Document Type: Article

References (31)

1. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL (2009). Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys, 486, 95-102.
2. Bhardwaj A, Aggarwal BB (2003). Receptor-mediated choreography of life and death. J Clin Immunol, 23, 317-32.
3. Carbone C, Melisi D (2012). NF-1B as a target for pancreatic cancer therapy. Expert Opin Ther Targets, 16, S1-10.
4. Cardone MH, Roy N, Stennicke HR, et al (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21.
5. Chen XQ, Yang S, Li ZY, et al (2012). Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells. Mol Med Report, 5, 917-22.
6. Chida N (2011). Recent advances in the synthesis of morphine and related alkaloids. Top Curr Chem, 299, 1-28.
7. Dai D, Liang Y, Xie Z, et al (2012). Survivin deficiency induces apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells. Oncol Rep, 27, 621-7.
8. D'Amelio M, Cavallucci V, Cecconi F (2010). Neuronal caspase-3 signaling: not only cell death. Cell Death Differ, 17, 1104-1.
9. El Mouedden M, Meert TF (2007). The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain. Pharmacol Biochem Behav, 87, 30-40.
10. Du GJ, Wang CZ, Zhang ZY, et al (2012). Caspase-mediated proapoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells. J Pharm Pharmacol, 64, 727-34.
11. Fujioka N, Nguyen J, Chen C, et al (2011). Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg, 113, 1353-64.
12. Green DR, Reed JC (1998). Mitochondria and apoptosis. Science, 281, 1309-12.
13. Hara S (2008). Opioids for metastatic bone pain. Oncology, 74, 52-4.
14. Hatzoglou A, Bakogeorgou E, Castanas E (1996). The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol, 296, 199-207.
15. Ibrahim AM, Mansour IM, Wilson MM, et al (2012). Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML). Lab Hematol, 18, 1-10.
16. Idenoue S, Hirohashi Y, Torigoe T, et al (2005). A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res, 11, 1474-82.
17. Ishikawa M, Tanno K, Kamo A, et al (1993). Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull, 16, 762-6.
18. Khan NI, Cisterne A, Baraz R, Bradstock KF, Bendall LJ (2012). Para-NO-aspirin inhibits NF-1B and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia. Exp Hematol, 40, 207-15.
19. Kumar S (1997). The apoptotic cysteine protease CPP32. Int J Biochem Cell Biol, 29, 393-6.
20. Maneckjee R, Minna JD (1994). Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ, 5, 1033-40.
21. Martin SJ, Green DR (1995). Protease activation during apoptosis: death by a thousand cuts1 Cell, 82, 349-52.
22. Pacifico F, Mauro C, Barone C, et al (2004). Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas. J Biol Chem, 279, 54610-9.
23. Page GG, Ben-Eliyahu S, Liebeskind JC (1994). The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun, 8, 241-50.
24. Page GG, McDonald JS, Ben-Eliyahu S (1998). Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth, 81, 216-23.
25. Payabvash S, Beheshtian A, Salmasi AH, et al (2006). Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver. Life Sci, 79, 972-80.
26. Singleton PA, Lingen MW, Fekete MJ, et al (2006). Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res, 72, 3-11.
27. Stefano GB, Fricchione GL, Goumon Y, Esch T (2005). Pain, immunity, opiate and opioid compounds and health. Med Sci Monit, 11, MS47-53.
28. Sueoka E, Sueoka N, Kai Y, et al (1998). Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun, 252, 566-70.
29. Suzuki A, Shiraki K (2001). Tumor cell ''dead or alive'': caspase and survivin regulate cell death, cell cycle and cell survival. Histol Histopathol, 16, 583-93.
30. Yang Y, Yu X (2003). Regulation of apoptosis: the ubiquitous way. FASEB J, 17, 790-9.
31. Yin D, Woodruff M, Zhang Y, et al (2006). Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J Neuroimmunol, 174, 101-7.